GlassScriptPhysician profile
Cynthia Garrett
NPI 1295963007
$1,073.57
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $457 · 2021: $212 · 2022: $209.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $201.44 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.66 | 2019-2022 | |
| Allergan, INC. | $122.58 | 2020 | |
| Pfizer INC. | $85.34 | 2021-2022 | |
| Lilly USA, LLC | $66.57 | 2021-2022 | |
| Novo Nordisk INC | $66.10 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $52.53 | 2020 | |
| Astellas Pharma US INC | $50.91 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.03 | 2020 | |
| Genentech USA, INC. | $32.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.76 | 2021 | |
| Abbott Laboratories | $25.85 | 2019 | |
| Abbvie INC. | $18.45 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.02 | 2022 | |
| Gilead Sciences, INC. | $16.94 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.74 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.69 | 2022 | |
| Glaxosmithkline, LLC. | $13.41 | 2022 | |
| Hikma Pharmaceuticals USA | $12.83 | 2019 | |
| Adlon Therapeutics L.P. | $11.42 | 2020 | |
| Amarin Pharma, INC. | $11.38 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.